共 50 条
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
被引:329
|作者:
Giannakakis, Antonis
[4
]
Sandaltzopoulos, Raphael
[4
]
Greshock, Joel
[2
]
Liang, Shun
Huang, Jia
[2
]
Hasegawa, Kosei
Li, Chunsheng
O'Brien-Jenkins, Ann
Katsaros, Dionyssios
[3
]
Weber, Barbara L.
[2
]
Simon, Celeste
[2
]
Coukos, George
[2
]
Zhang, Lin
[1
]
机构:
[1] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[3] Univ Turin, Dept Obstet & Gynecol, Turin, Italy
[4] Democritus Univ Thrace, Dept Mol Biol & Genet, Lab Gene Express Mol Diagnost & Modern Therapeut, Alexandroupolis, Greece
关键词:
microRNA;
hypoxia;
ovarian cancer;
D O I:
10.4161/cbt.7.2.5297
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
cancer pathogenesis. We studied miRNA genes that are regulated by hypoxia in ovarian cancer cell lines by TaqMan miRNA assay containing 157 mature miRNAs. MiR-210 was the most prominent miRNA consistently stimulated under hypoxic conditions. We provide evidence for the involvement of the HIF signaling pathway in miR-210 regulation. Biocomputational analysis and in vitro assays demonstrated that e2f transcription factor 3 (e2f3), a key protein in cell cycle, is regulated by miR-210. E2F3 was further confirmed to be downregulated at the protein level upon induction of miR-210. Importantly, we found remarkably high frequency of miR-210 gene copy deletions in ovarian cancer patients (64%, n = 114) and that gene copy number correlates with miR-210 expression levels. Taken together, our results indicate that miR-210 plays a crucial role in tumor onset as a key regulator of the hypoxia response and provide evidence for a link between hypoxia and the regulation of cell cycle.
引用
收藏
页码:255 / 264
页数:10
相关论文